You are here: Industry Insights > WPD Pharmaceuticals

News List

WPD Partners with CNS on Drug Development for Coronavirus, Other Antiviral Indication americanpharmaceuticalreview
March 26, 2020
WPD Pharmaceuticals has entered into a development agreement with CNS Pharmaceuticals for the development of several preclinical drug candidates including WP1122.
WPD Pharmaceuticals’ Brain Cancer Drug Received Positive FDA Pre-IND Guidance americanpharmaceuticalreview
March 05, 2020
WPD Pharmaceuticals has provided an update that through its license partner, CNS Pharmaceuticals, it received positive feedback from the U.S. Food and Drug Administration (FDA) for its Pre-IND ...
Westcot Ventures Corp. Announces Closing of Transaction of WPD Pharmaceuticals Sp. Z.o.o. firstwordpharma
December 24, 2019
Pursuant to the completion of the Transaction, the Company issued 67,000,000 common shares to the WPD Securityholders in exchange for 100% of the issued and outstanding securities of WPD. Upon completion of the Transaction, WPD has become a wholly-owned s